Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-05-22 Sale | 2019-05-24 4:00 pm | Sage Therapeutics Inc. | SAGE | Cloonan Michael Chief Business Officer | 25,000 | $175 | $4,375,000 | 160,461 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-02-10 Option Award | 2021-02-12 4:01 pm | N/A 2031-02-10 | Sage Therapeutics Inc. | SAGE | Cloonan Michael Chief Business Officer | 19,000 | $0 | 19,000 (Direct) | View |
| 2020-05-01 Option Award | 2020-05-05 4:58 pm | N/A 2030-05-01 | Sage Therapeutics Inc. | SAGE | Cloonan Michael Chief Business Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2020-04-28 Option Award | 2020-04-30 4:44 pm | N/A 2030-04-28 | Sage Therapeutics Inc. | SAGE | Cloonan Michael Chief Business Officer | 9,450 | $0 | 9,450 (Direct) | View |
| 2020-02-12 Option Award | 2020-02-14 4:56 pm | N/A 2030-02-12 | Sage Therapeutics Inc. | SAGE | Cloonan Michael Chief Business Officer | 22,500 | $0 | 22,500 (Direct) | View |
| 2019-07-25 Option Award | 2019-07-29 8:00 pm | N/A N/A | Sage Therapeutics Inc. | SAGE | Cloonan Michael Chief Business Officer | 2,450 | $0 | 2,102 (Direct) | View |
| 2019-07-25 Tax Withholding | 2019-07-29 8:00 pm | N/A N/A | Sage Therapeutics Inc. | SAGE | Cloonan Michael Chief Business Officer | 1,088 | $161.38 | 2,102 (Direct) | View |
| 2019-05-22 Exercise | 2019-05-24 4:00 pm | N/A 2027-05-01 | Sage Therapeutics Inc. | SAGE | Cloonan Michael Chief Business Officer | 25,000 | $0 | 160,461 (Direct) | View |
| 2019-05-22 Exercise | 2019-05-24 4:00 pm | N/A N/A | Sage Therapeutics Inc. | SAGE | Cloonan Michael Chief Business Officer | 25,000 | $73.43 | 160,461 (Direct) | View |